Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Research & Development (2019 - 2025)

IDEAYA Biosciences' Research & Development history spans 7 years, with the latest figure at $86.6 million for Q4 2025.

  • For Q4 2025, Research & Development fell 38.22% year-over-year to $86.6 million; the TTM value through Dec 2025 reached $314.7 million, up 6.8%, while the annual FY2025 figure was $314.7 million, 6.8% up from the prior year.
  • Research & Development for Q4 2025 was $86.6 million at IDEAYA Biosciences, up from $83.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $140.2 million in Q4 2024 and bottomed at $11.6 million in Q1 2021.
  • The 5-year median for Research & Development is $31.4 million (2023), against an average of $44.3 million.
  • The largest annual shift saw Research & Development skyrocketed 261.58% in 2024 before it tumbled 38.22% in 2025.
  • A 5-year view of Research & Development shows it stood at $16.1 million in 2021, then soared by 53.4% to $24.7 million in 2022, then skyrocketed by 56.88% to $38.8 million in 2023, then surged by 261.58% to $140.2 million in 2024, then tumbled by 38.22% to $86.6 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Research & Development are $86.6 million (Q4 2025), $83.0 million (Q3 2025), and $74.2 million (Q2 2025).